E7-6166. Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications
-
Start Preamble
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Notice.
SUMMARY:
The Food and Drug Administration (FDA) is publishing a list of premarket approval applications (PMAs) that have been approved. This list is intended to inform the public of the availability of safety and effectiveness summaries of approved PMAs through the Internet and the agency's Division of Dockets Management.
ADDRESSES:
Submit written requests for copies of summaries of safety and effectiveness to the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. Please cite the appropriate docket number as listed in table 1 of this document when submitting a written request. See the SUPPLEMENTARY INFORMATION section for electronic access to the summaries of safety and effectiveness.
Start Further InfoFOR FURTHER INFORMATION CONTACT:
Thinh Nguyen, Center for Devices and Radiological Health (HFZ-402), Food and Drug Administration, 9200 Start Printed Page 15886Corporate Blvd., Rockville, MD 20850, 301-594-2186, ext. 152.
End Further Info End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
I. Background
In the Federal Register of January 30, 1998 (63 FR 4571), FDA published a final rule that revised 21 CFR 814.44(d) and 814.45(d) to discontinue individual publication of PMA approvals and denials in the Federal Register. Instead, the agency now posts this information on the Internet on FDA's Web site at http://www.fda.gov. FDA believes that this procedure expedites public notification of these actions because announcements can be placed on the Internet more quickly than they can be published in the Federal Register, and FDA believes that the Internet is accessible to more people than the Federal Register.
In accordance with section 515(d)(4) and (e)(2) of the Federal Food, Drug, and Cosmetic Act (the act) (21 U.S.C. 360e(d)(4) and (e)(2)), notification of an order approving, denying, or withdrawing approval of a PMA will continue to include a notice of opportunity to request review of the order under section 515(g) of the act. The 30-day period for requesting reconsideration of an FDA action under § 10.33(b) (21 CFR 10.33(b)) for notices announcing approval of a PMA begins on the day the notice is placed on the Internet. Section 10.33(b) provides that FDA may, for good cause, extend this 30-day period. Reconsideration of a denial or withdrawal of approval of a PMA may be sought only by the applicant; in these cases, the 30-day period will begin when the applicant is notified by FDA in writing of its decision.
The regulations provide that FDA publish a quarterly list of available safety and effectiveness summaries of PMA approvals and denials that were announced during that quarter. The following is a list of approved PMAs for which summaries of safety and effectiveness were placed on the Internet from October 1, 2006, through December 31, 2006. There were no denial actions during this period. The list provides the manufacturer's name, the product's generic name or the trade name, and the approval date.
Table 1.—List of Safety and Effectiveness Summaries for Approved PMAs Made Available From October 1, 2006, through December 31, 2006.
PMA No./Docket No. Applicant Trade Name Approval Date P040027/2006M-0411 W.L. Gore & Associates GORE VIATORR TIPS December 6, 2004 P040023/2006M-0512 DePuy Orthopedics, Inc. DURALOC OPTION CERAMIC HIP SYSTEM May 3, 2005 P030047/2006M-0412 Cordis Corp. CORDIS PRECISE NITINOL STENT September 22, 2006 P050038/2006M-0396 Medafor, Inc. ARISTA AH ABSORBABLE HEMOSTATIC, NON-COLLAGEN BASED September 26, 2006 P970053(S9)/2006M-0460 Nidek, Inc. NIDEK EC-5000 EXCIMER LASER October 11, 2006 P050022/2006M-0456 Siemens Medical Solutions USA, Inc. SYNGO LUNG COMPUTER ASSISTED DETECTION (CAD) SYSTEM October 18, 2006 P050025/2006M-0459 Endotex Interventional Systems, Inc. ENDOTEX NEXSTENT CAROTID STENT & DELIVERY SYSTERM; AND ENDOTEX NEXSTENT CAROTID STENT & MONORAIL DELIVERY SYSTERM October 27, 2006 P020012/2006M-0455 Artes Medical USA, Inc. ARTEFILL October 27, 2006 P040050/2006M-0457 Uroplasty, Inc. MACROPLASTIQUE IMPLANTS October 30, 2006 P050031/2006M-0473 Paragon Vision Sciences PARAGON Z CRT November 16, 2006 P020056/2006M-0490 Allergan INAMED SILICONE-FILLED BREAST IMPLANTS November 17, 2006 P030053/2006M-0492 Mentor Corp. MENTOR MEMORYGEL SILICONE GEL-FILLED BREAST IMPLANTS November 17, 2006 P060010/2006M-0529 AbbeyMoor Medical, Inc. THE SPANNER TEMPORARY PROSTATIC STENT December 14, 2006 P040025/2006M-0530 Olympic Medical OLYMPIC COOL-CAP December 20, 2006 P050033/2006M-0531 Anika Therapeutics, Inc. COSMETIC TISSUE AUGMENTATION PRODUCT December 20, 2006 II. Electronic Access
Persons with access to the Internet may obtain the documents at http://www.fda.gov/cdrh/pmapage.html.
Start SignatureDated: March 22, 2007.
Linda S. Kahan,
Deputy Director, Center for Devices and Radiological Health.
[FR Doc. E7-6166 Filed 4-2-07; 8:45 am]
BILLING CODE 4160-01-S
Document Information
- Published:
- 04/03/2007
- Department:
- Food and Drug Administration
- Entry Type:
- Notice
- Action:
- Notice.
- Document Number:
- E7-6166
- Pages:
- 15885-15886 (2 pages)
- Docket Numbers:
- Docket Nos. 2006M-0411, 2006M-0512, 2006M-0412, 2006M-0396, 2006M-0460, 2006M-0456, 2006M-0459, 2006M-0455, 2006M-0457, 2006M-0473, 2006M-0490, 2006M-0492, 2006M-0529, 2006M-0530 and 2006M-0531
- PDF File:
- e7-6166.pdf